Oncology

Acute Myeloid Leukemia

Advertisment

Expert Perspectives in Acute Myeloid Leukemia to Cover Key Topics in AML

expert perspectives by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE
Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives in Acute Myeloid Leukemia (AML) will feature community-selected experts and topics that we hope you will find of value in your clinical practice.

 

To set the stage for our dedicated coverage of Acute Myeloid Leukemia, the following articles highlight the current challenges, opportunities, and new frontiers in Acute Myeloid Leukemia.

 

 


VIEW THE TOPICS

 

  • Approach to Patients With AML Who Are Ineligible for Intensive Chemotherapy
    Courtney D. DiNardo, MD, MSCE

 

  • Combination Strategies to Overcome Hypomethylating Agent Resistance
    Courtney D. DiNardo, MD, MSCE

 

  • Maintenance Therapy Post Allogeneic Stem Cell Transplantation in AML
    Andrew M. Brunner, MD

 

  • Relapsed AML: Past, Present, and Future
    Courtney D. DiNardo, MD, MSCE

 

  • Updates on TP53-Mutant AML
    Andrew M. Brunner, MD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Andrew M. Brunner, MD

Assistant Professor of Medicine
Harvard Medical School
Assistant in Medicine, Division of Hematology and Oncology
Center for Leukemia, Massachusetts General Hospital Cancer Center
Massachusetts General Hospital
Boston, MA

Courtney D. DiNardo, MD, MSCE

Professor of Medicine
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Advertisment